Our priority: international standards and high-performance quality

To ensure international standards of research and high-performance quality, the institute submits its activities to regular reviews through a board of independent scientists. Every three years the CCRI is assessed by members of a scientific advisory board (SAB). This panel of independent, internationally acknowledged scientists meets at the CCRI to discuss scientific issues with the institute's researchers. Subsequently, the SAB provides a detailed report about the CCRI`s activities with suggestions about future directions and possible improvements.

Therefore, we extend our gratitude to all members of the scientific advisory board, past and present. The members of our scientific advisory board are the following:

PROF. DR. KLAUS-MICHAEL DEBATIN
Universitätsklinik für Kinder- und Jugendmedizin, 89075 Ulm, Germany 

PROF. JAMES R. DOWNING, MD
Scientific Director, St. Jude Children’s Research Hospital, Memphis, TN 38105-3678, USA 

PROF. LEE J. HELMAN, MD
Scientific Director for Clinical Research, Center for Cancer Research National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-2440, USA 

PROF. STEPHAN LADISCH, MD
Bosworth Chair for Cancer Biology Center for Cancer and Immunology Research, Children’s National Medical Center, Washington, DC 20010, USA 

PROF. MEGAN SYKES, MD
Columbia University Medical Center, New York, NY 10032, USA 

PROF. JOSEF VORMOOR, MD
Newcastle Cancer Centre at the Northern Institute for Cancer Research Newcastle University, Paul O’Gorman Building, Medical School, Framlington Place, Newcastle upon Tyne, NE2 4HH